Nexalin Technology (NXL) Net Shares Issued and Repurchased (2023 - 2025)
Nexalin Technology (NXL) posted Net Shares Issued and Repurchased of $1.1 million for Q4 2025, up 25.52% on a QoQ basis from $856870.0 in Q4 2024, and up 25.52% year-over-year from $856870.0 in Q4 2024.
Analysis
Nexalin Technology (NXL) Net Shares Issued and Repurchased (2023 - 2025) Analysis & Trends
Nexalin Technology has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $1.1 million in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 25.52% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 25.52% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 25.52% from the prior year.
- Net Shares Issued and Repurchased was $1.1 million for Q4 2025 at Nexalin Technology, up from $856870.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $2.3 million in Q4 2023, with the low at $856870.0 in Q4 2024.
- Average Net Shares Issued and Repurchased over 3 years is $1.6 million, with a median of $1.7 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased sank 62.45% in 2024, then advanced 25.52% in 2025.
- Over 3 years, Net Shares Issued and Repurchased stood at $2.3 million in 2023, then tumbled by 62.45% to $856870.0 in 2024, then gained by 25.52% to $1.1 million in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $1.1 million (Q4 2025), $856870.0 (Q4 2024), and $2.3 million (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 856,870.00 |
| Mar 31, 2024 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |